Tango Therapeutics Inc (TNGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Sales | 5,431 | 10,732 | 14,598 | 5,766 | 6,411 |
| Gross Profit | 5,431 | 10,732 | 14,598 | 5,766 | 6,411 |
| Operating Expenses | 40,445 | 36,358 | 37,845 | 36,052 | 36,978 |
| Operating Income | -35,014 | -25,626 | -23,247 | -30,286 | -30,567 |
| Other Income | 4,298 | 3,386 | 2,601 | 2,278 | 1,558 |
| Pre-tax Income | -30,716 | -22,240 | -20,646 | -28,008 | -29,009 |
| Income Tax | 47 | 23 | 64 | N/A | 51 |
| Net Income Continuous | -30,763 | -22,263 | -20,710 | -28,008 | -29,060 |
| Net Income | $-30,763 | $-22,263 | $-20,710 | $-28,008 | $-29,060 |
| EPS Basic Total Ops | -0.30 | -0.23 | -0.23 | -0.32 | -0.33 |
| EPS Basic Continuous Ops | -0.29 | -0.23 | -0.23 | -0.32 | -0.33 |
| EPS Diluted Total Ops | -0.30 | -0.23 | -0.23 | -0.32 | -0.33 |
| EPS Diluted Continuous Ops | -0.29 | -0.23 | -0.23 | -0.32 | -0.33 |
| EBITDA(a) | $-36,761 | $-24,274 | $-23,519 | $-30,598 | $-29,778 |